Use to diagnose Gaucher disease only; not indicated for carrier screening.
Yellow (ACD), Lavender (K2EDTA), Lavender (K3EDTA), or Green (Sodium Heparin).
Transport 3 mL whole blood. (Min: 1 mL)
Grossly hemolyzed specimens.
Additional information is required: Clinical Indication for testing.
Ambient: Unacceptable; Refrigerated: 3 days; Frozen: Unacceptable
4.6 - 12.0 nmol hydrolyzed/hr/mg protein
Refer to report.
Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
|Component Test Code*||Component Chart Name||LOINC|
|2014460||Gaucher GBA Activity Leukocytes Interp||48767-8|
|2014461||Gaucher GBA Activity Leukocytes||32540-7|